Enteric bacterial toxin

Enteric bacterial toxins are a diverse group of exotoxins produced by pathogenic bacteria in the gastrointestinal tract, including species such as Vibrio cholerae, Escherichia coli, and Clostridioides difficile (StatPearls, 2023). These toxins typically function by disrupting host cellular processes, such as ion transport, protein synthesis, or cytoskeletal integrity, leading to symptoms like severe diarrhea, inflammation, and tissue damage (Nature Reviews Microbiology, 2004). For instance, cholera toxin and heat-labile enterotoxins increase intracellular cyclic AMP levels, while Shiga toxins inhibit ribosomal function by cleaving 28S rRNA (CDC, 2022). Therapeutically, these toxins are targeted by neutralizing monoclonal antibodies, such as bezlotoxumab which targets C. difficile toxin B, or by sequestering agents like cholestyramine that bind toxins within the gut lumen (FDA, 2016; Mayo Clinic, 2023). Understanding the specific molecular mechanisms of these toxins is crucial for developing targeted interventions to treat infectious diarrheal diseases and their systemic complications like Hemolytic Uremic Syndrome (PubMed, 2021). These toxins are often classified into categories such as enterotoxins, which affect the intestines, and cytotoxins, which cause direct cell death (UniProt).

Other names

Bacterial enterotoxinGastrointestinal exotoxinIntestinal bacterial toxinEnteric exotoxin

Neutralization of toxin activity by monoclonal antibodies, sequestration and adsorption of toxins in the gastrointestinal lumen, and inhibition of toxin-mediated intracellular signaling pathways (FDA, 2016; Mayo Clinic, 2023).